Home health equipment maker Invacare (NYSE:IVC) has hired a chief compliance officer who previously held the role with Endo Pharmaceuticals (NASDAQ:ENDP). Colleen Craven’s role will be to ensure that Invacare is compliant with “relevant laws and regulations regarding the design, manufacture and distribution of medical devices,” according to a statement from the company. Invacare’s regulatory […]
Home health products maker Invacare Corp.'s (NYSE:IVC) fourth-quarter adjusted earnings beat Wall Street analysts' expectations, thanks to organic sales growth and reduced interest expenses.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Cardinal Health (NYSE: CAH), Ohio's largest company by revenues, led the state's health organizations in federal lobbying spending last year at nearly $1.3 million. Cardinal, a pharmaceuticals distributor and medical products supplier, upped its federal lobbying spending by 39 percent over the prior year, publicly filed lobbying reports revealed.
For most medical device companies, the occasional warning letter from the U.S. Food and Drug Administration is just a minor annoyance, another part of doing business. But a recent FDA warning letter to home health products manufacturer Invacare Corp. (NYSE:IVC) that contained unsubstantiated reports of fires, entrapments and deaths caused by the company's adjustable electric beds holds the potential to be much more harmful to the company than the typical warning letter. The key word there is "potential."
Invacare Corp. (NYSE:IVC) has been slapped with a warning letter by federal regulators for failing to adequately investigate reports of fires and sparks caused by electric beds that in some cases allegedly resulted in patient deaths.
Mal Mixon led Invacare for three decades and powered wheelchair sales as well as the company's identity. Read about five key moments in Mixon's leadership at Invacare, including his initial $10,000 investment and his innovations in motorized wheelchairs.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
General James L. Jones, a recently retired national security advisor to President Obama, has joined the board of Invacare Corp. (NYSE:IVC), replacing departing Ohio Governor-elect John Kasich.
Invacare Corp. (NYSE:IVC) CEO A. Malachi Mixon III, a name synonymous with the company since he bought it with his life savings in 1979, is stepping down from his chief executive post but will stay on as chairman. Gerald Blouch, who's been working as the home health products maker's interim CEO since April, will succeed Mixon in the chief executive role.
Invacare Corp. (NYSE:IVC) has purchased nearly $143 million in high-yield senior notes as the home healthcare equipment maker continues to reduce its debt load.
Home healthcare products maker Invacare Corp. (NYSE:IVC) is taking steps -- notably, reducing and refinancing its debt -- to be poised to make acquisitions, as well as return to historic sales growth rates. When might those things happen? Even executives of the Elyria, Ohio, company can't say.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Invacare Corp. (NYSE:IVC) is offering to buy back $146 million-worth of senior notes that come due in 2015 in a continuing effort to reduce its load of high-cost debt. Invacare is offering to pay $1,045 per $1,000 note until Nov. 1. Sellers who tender their shares by Oct. 15 will get an additional $30 "consent payment," or $1,075 per $1,000 note.
Thanks to a recent focus on debt reduction, home health equipment maker Invacare Corp. had its corporate credit rating boosted by Standard & Poor's.
The International Trade Commission is looking into claims by home healthcare product maker Invacare Corp. (NYSE: IVC) that a New York distributor and its Chinese manufacturer are infringing on the Ohio company's patented universal bed technology.
A group of Northeast Ohio business leaders and elected officials objects to a TV ad from Gov. Ted Strickland that they say casts Invacare Corp. in a negative light for outsourcing jobs.
Home medical products maker Invacare Corp. (NYSE: IVC) has taken center stage in Ohio's gubernatorial election, thanks to a TV ad from Gov. Ted Strickland that criticizes the outsourcing of Ohio jobs.